Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Novello

Showing results (791-800 of 1,095) with videos related to

Pageof 110
Sort By:
Critical Reviews in Oncology/Hematology|March 21, 2021
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspectiveUmberto Malapelle, Sara Pilotto, Francesco Passiglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.
The Lancet. Oncology|January 14, 2014
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trialMartin Reck, Rolf Kaiser, Anders Mellemgaard, et al.
Toxicology Letters|January 3, 2026
Predicting acute developmental toxicity of chemicals in embryos of the African clawed frog (Xenopus laevis): calibration and validation of regression-based quantitative structure activity relationship models for hazard assessment of chemicals in anuran amphibiansChristian Novello, Matteo Riccardo Di Nicola, Jean Lou Cm Dorne, et al.
RSC Medicinal Chemistry|January 8, 2025
Novel sigma 1-antagonists with <i>cis</i>-(+)-normetazocine scaffold: synthesis, molecular modeling, and antinociceptive effectGiuliana Costanzo, Giuseppe Cosentino, Margherita Grasso, et al.
International Journal of Molecular Sciences|September 28, 2024
Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with CarcinomaLudmilla Thomé Domingos Chinen, Jacqueline Aparecida Torres, Vinicius Fernando Calsavara, et al.
Microorganisms|May 28, 2022
Proteome and Physiological Characterization of Halotolerant Nodule Endophytes: The Case of <i>Rahnella aquatilis</i> and <i>Serratia plymuthica</i>Giorgia Novello, Elisa Gamalero, Nadia Massa, et al.
Military Medicine|February 20, 2020
Experimental Basis for Creating an Osseointegrated Neural Interface for Prosthetic Control: A Pilot Study in RabbitsAaron M Dingle, Jared P Ness, Joseph Novello, et al.
Cancer Treatment and Research Communications|April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysisS Ponce Aix, S Novello, E B Garon, et al.
Oncogene|July 8, 2018
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistanceRossella Loria, Valentina Laquintana, Giulia Bon, et al.
Pageof 110

Showing results (791-800 of 1,095) with videos related to

Sort By:
Pageof 110
Critical Reviews in Oncology/Hematology|March 21, 2021
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspectiveUmberto Malapelle, Sara Pilotto, Francesco Passiglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2012
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidS Vadhan-Raj, R von Moos, L J Fallowfield, et al.
The Lancet. Oncology|January 14, 2014
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trialMartin Reck, Rolf Kaiser, Anders Mellemgaard, et al.
Toxicology Letters|January 3, 2026
Predicting acute developmental toxicity of chemicals in embryos of the African clawed frog (Xenopus laevis): calibration and validation of regression-based quantitative structure activity relationship models for hazard assessment of chemicals in anuran amphibiansChristian Novello, Matteo Riccardo Di Nicola, Jean Lou Cm Dorne, et al.
RSC Medicinal Chemistry|January 8, 2025
Novel sigma 1-antagonists with <i>cis</i>-(+)-normetazocine scaffold: synthesis, molecular modeling, and antinociceptive effectGiuliana Costanzo, Giuseppe Cosentino, Margherita Grasso, et al.
International Journal of Molecular Sciences|September 28, 2024
Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with CarcinomaLudmilla Thomé Domingos Chinen, Jacqueline Aparecida Torres, Vinicius Fernando Calsavara, et al.
Microorganisms|May 28, 2022
Proteome and Physiological Characterization of Halotolerant Nodule Endophytes: The Case of <i>Rahnella aquatilis</i> and <i>Serratia plymuthica</i>Giorgia Novello, Elisa Gamalero, Nadia Massa, et al.
Military Medicine|February 20, 2020
Experimental Basis for Creating an Osseointegrated Neural Interface for Prosthetic Control: A Pilot Study in RabbitsAaron M Dingle, Jared P Ness, Joseph Novello, et al.
Cancer Treatment and Research Communications|April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysisS Ponce Aix, S Novello, E B Garon, et al.
Oncogene|July 8, 2018
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistanceRossella Loria, Valentina Laquintana, Giulia Bon, et al.
Pageof 110